SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

DALLOCCHIO, Franco Pasquale Filippo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.573
AS - Asia 8.501
EU - Europa 4.377
SA - Sud America 1.325
Continente sconosciuto - Info sul continente non disponibili 213
AF - Africa 194
OC - Oceania 18
Totale 30.201
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.232
SG - Singapore 3.061
CN - Cina 2.366
BR - Brasile 1.018
UA - Ucraina 921
VN - Vietnam 900
DE - Germania 809
HK - Hong Kong 645
IT - Italia 585
TR - Turchia 553
GB - Regno Unito 468
FI - Finlandia 359
FR - Francia 259
RU - Federazione Russa 247
JP - Giappone 239
SE - Svezia 236
BD - Bangladesh 169
IN - India 168
PL - Polonia 162
CA - Canada 150
MX - Messico 116
AR - Argentina 96
ZA - Sudafrica 64
ID - Indonesia 59
IQ - Iraq 51
CO - Colombia 50
ES - Italia 50
NL - Olanda 48
EC - Ecuador 40
EE - Estonia 37
PK - Pakistan 37
VE - Venezuela 36
CZ - Repubblica Ceca 33
PH - Filippine 31
BE - Belgio 29
MY - Malesia 29
UZ - Uzbekistan 28
CL - Cile 27
MA - Marocco 27
LT - Lituania 24
PY - Paraguay 22
SA - Arabia Saudita 22
JM - Giamaica 18
AT - Austria 17
IR - Iran 16
TN - Tunisia 16
ET - Etiopia 15
EG - Egitto 14
AU - Australia 13
AE - Emirati Arabi Uniti 12
BO - Bolivia 12
KE - Kenya 12
AZ - Azerbaigian 11
DZ - Algeria 11
IE - Irlanda 11
PE - Perù 11
UY - Uruguay 11
BG - Bulgaria 10
CR - Costa Rica 10
HN - Honduras 10
RO - Romania 10
EU - Europa 9
IL - Israele 9
LB - Libano 9
SD - Sudan 9
KR - Corea 8
NP - Nepal 8
OM - Oman 8
AL - Albania 7
CH - Svizzera 7
JO - Giordania 7
NI - Nicaragua 7
PS - Palestinian Territory 7
PT - Portogallo 7
AO - Angola 6
KZ - Kazakistan 6
LV - Lettonia 6
SV - El Salvador 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
GE - Georgia 5
NZ - Nuova Zelanda 5
BY - Bielorussia 4
DK - Danimarca 4
GT - Guatemala 4
KG - Kirghizistan 4
KW - Kuwait 4
MD - Moldavia 4
MT - Malta 4
PA - Panama 4
QA - Qatar 4
RS - Serbia 4
TH - Thailandia 4
BB - Barbados 3
BH - Bahrain 3
CY - Cipro 3
GR - Grecia 3
MK - Macedonia 3
SN - Senegal 3
Totale 29.958
Salva come PNG Salva come JPEG
Città #
Singapore 1.960
Ashburn 1.335
Woodbridge 1.295
San Jose 1.140
Jacksonville 1.003
Chandler 962
Fairfield 893
Houston 796
Santa Clara 730
Beijing 683
Hong Kong 626
Ann Arbor 570
Council Bluffs 488
Wilmington 401
Dallas 349
Izmir 305
Seattle 296
Nanjing 287
Ho Chi Minh City 279
Cambridge 263
Los Angeles 230
Tokyo 229
Princeton 209
Hanoi 204
New York 181
Munich 180
Boardman 169
Dearborn 168
Lauterbourg 158
Warsaw 149
Ferrara 125
Shenyang 108
Nanchang 105
Helsinki 103
San Diego 100
São Paulo 99
Milan 96
Shanghai 85
Tianjin 82
Changsha 73
Phoenix 69
Buffalo 64
Mexico City 62
Turku 62
Addison 61
Hebei 59
Orem 58
Chicago 57
Hefei 54
Toronto 54
London 52
Da Nang 51
Bremen 49
Jiaxing 47
Chennai 46
Brooklyn 45
Montreal 43
San Francisco 43
Frankfurt am Main 41
Mountain View 38
Moscow 37
Stockholm 37
Haiphong 36
Atlanta 34
Guangzhou 34
Jinan 34
Ningbo 34
Redwood City 33
Denver 32
Poplar 31
Orange 30
Kunming 29
Manchester 28
Norwalk 28
Bologna 27
San Mateo 27
Brno 26
Brussels 26
Rome 26
Boston 25
Biên Hòa 24
Tashkent 24
Zhengzhou 24
Amsterdam 23
Düsseldorf 23
Johannesburg 23
Washington 23
Rio de Janeiro 22
The Dalles 22
Augusta 20
Baghdad 20
Curitiba 20
Mumbai 20
Philadelphia 20
Auburn Hills 19
Leawood 18
Belo Horizonte 16
Falkenstein 16
Ninh Bình 16
Dhaka 15
Totale 19.591
Salva come PNG Salva come JPEG
Nome #
Thermodynamic characterization of substrate and inhibitor binding to Trypanosoma brucei 6-phosphogluconate dehydrogenase 310
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 283
6-Phosphogluconate dehydrogenase from Trypanosoma brucei - Kinetic analysis and inhibition by trypanocidal drugs 265
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 260
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 255
Differentiation between the structural and redox roles of TPNH in 6-phosphogluconate dehydrogenase 250
6-phosphogluconate dehydrogenase: structural symmetry and functional asymmetry 247
Role of Methionine 13 in the catalytic mechanism of 6-phosphogluconate dehydrogenase from sheep liver 243
A role for the pyridine nitrogen of reduced triphosphopyridine-nucleotide in the mechanism of action of isocitrate dehydrogenase 242
Antiprotozoal activity of 6-aminonicotinamide against Leishmania infantum promastigotes 239
A new powerful inhibitor specific for the TPN binding site of 6-phosphogluconate dehydrogenase 238
A rapid method for purification of myelin basic protein 232
Inhibitors of Trypanosoma brucei 6-phosphogluconate dehydrogenase 230
A role for the pyridine nitrogen of reduced triphosphopyridinenucleotide in an enzymatic catalysis 224
HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies 224
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 224
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 222
Identification of the chemical groups involved in the binding of periodate-oxidized NADP+ to 6-phosphogluconate dehydrogenase. 216
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 213
A Real-Time PCR to Detect Leishmania Infantum DNA in Immunocompetent Patients with Chronic Inflammatory Rheumatisms Living in Rural Areas of Northern Italy and Treated with Biologic Drugs. 213
6-Phosphogluconate dehydrogenase: the mechanism of action investigated by a comparison of the enzyme from different species 212
Activation of the Sendai virus fusion protein by receptor binding 210
6-Phosphogluconate dehydrogenase mechanism: Evidence for allosteric modulation by substrate 209
Affinity labelling of the NADP+-binding site of glucose 6-phosphate dehydrogenase from Candida utilis 208
Activation of the sendai virus fusion protein by receptor binding 206
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 203
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 199
6-phosphogluconate dehydrogenase: a target for drugs in African trypanosomiasis 199
Mutual communication of envelope glycoproteins of paramixoviruses 197
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 197
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 197
Surface mapping of Env protein from HIV by chemical modifications 195
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 195
Isotope effect as a probe of the catalytic rilevance of coenzyme isomerization in the enzyme 6-phosphogluconate dehydrogenase from sheep liver 194
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 194
Proper orientation of the nicotinamide ring of NADP is important for the precatalytic conformational change in the 6-phosphogluconate dehydrogenase reaction 193
Analisi della proteina basica della mielina nel liquor 192
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 192
Le beta-esosaminidasi liquorali in sogetti affetti da sclerosi multipla e in controlli sani 189
Characterization of anti-coagulant properties of prenylated coumarin ferulenol. 188
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 187
Substrate binding to 6-phosphogluconate dehydrogenase 187
A new hypothesis on the mechanism of action of lamb liver 6-phosphogluconate dehydrogenase 184
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 183
X-ray escaping conformational changes affecting enzymatic function 183
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 181
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 181
X-ray escaping conformational changes affecting enzymatic function 179
"Do the two subunits of lamb liver 6-phosphogluconate dehydrogenase alternate their role during catalysis?" 179
Biochemical study in adult population with stroke in Ferrara, Fabry disease 179
A further non-redox role for NADPH in the mechanism of action of 6-pho-sphogluconate dehydrogenase from lamb liver 177
Features of hypereutrophic Molino lagoon ecosystem dominated by sedentary polychaetes 176
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 175
NADPH activates a decarboxylation reaction catalysed by lamb liver 6-phosphogluconate dehydrogenase 175
Role of methionine-13 in the catalytic mechanism of 6-phosphogluconate dehydrogenase from sheep liver 175
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 175
Thermodynamic characterization by ITC and DSC of the binding of 4-phospho-d-erythronate to the target enzyme T. brucei 6-phosphogluconate dehydrogenase 174
A multiple role for the coenzyme in the mechanism of action of 6-phosphogluconate dehydrogenase 174
A catalytic tyrosine at the active site of sendai virus neuraminidase 173
Cysteine 365 may have a role in the catalytic mechanism of 6-Phosphogluconate Dehydrogenase from Sheep Liver 173
Alternating site catalytic cooperativity in some 6-phosphogluconate dehydrogenases 173
Bromopyruvate for the affinity labelling of a single cysteine residue near the carboxylate binding site of lamb liver 6-phosphogluconate dehydrogenase 172
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 171
Non-enzymic protein phosphorylation. Phosphorylation of 6-phosphogluconate dehydrogenase by acyl phosphates 171
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 171
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 171
Isothermal titration calorimetry tool to better characterize the mechanism of T. brucei 6-phosphogluconate dehydrogenase 170
Evidences for the proximity of two sulfhydryl groups in the active site of 6-phosphogluconate dehydrogenase 169
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 168
Anomeric specificity of the neuraminidase from sendai virus 167
Substrate-induced intramolecular proton transfer in 6-phosphogluconate dehydrogenase from Candida utilis 166
Evidence for multiple pairs of vicinal thiols in some proteins 164
Evidence for the proximity of a cysteinyl and a tyrosyl residue in the active sita of 6-phosphogluconate dehydrogenase 163
Inhibition of Sendai virus hemagglutinin neuraminidase by the fusion protein 162
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 162
Sugar derivatives as new 6-phosphogluconate dehydrogenase inhibitors selective for the parasite Trypanosoma Brucei 161
The stabilization by a coenzyme analog of a conformational change induced by substrate in 6-phosphogluconate dehydrogenase 161
6-fosfogluconato deidrogenasi da eritrociti umani: interazione con i coenzimi 161
Alkylation of 6-phosphogluconate dehydrogenase from Candida utilis with coenzyme analogues 161
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 160
Use of Trinitrobenzensulfonate for Affinity Labeling of Lysine Residues at Phosphate Binding Sites of Some Enzymes 160
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 160
Elevato riscontro di DNA circolante di Leishmania infantum in soggetti immunocompetenti affetti da malattie reumatologiche e trattati con farmaci biotecnologici. 160
Pharmacological potential of inhibitors of 6-phosphogluconate dehydrogenase from T.brucei: differentiation of substrate analogues from reaction-intermediate analogues by isothermal titration calorimetry 159
Mild proteolysis induces a ready-to-fuse state on Sendai virus envelope 158
Energy cost for the proper ionization of active site residues in 6-phosphogluconate dehydrogenase from T. brucei 158
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 158
The mechanism of 6PGDH investigated by kinetics isotope effects 158
Dynamics of phosphorus in the Venice lagoon during a picocyanobacteria bloom 157
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 156
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 156
Is there an alternating site co-operativity between the two subunits of lamb liver 6-phosphogluconate dehydrogenase? 154
Evidence for dimer/tetramer equilibrium in Trypanosoma brucei 6-phosphogluconate dehydrogenase 153
Domain structure of the hemagglutinin-neuraminidase from sendai virus 150
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 148
Myelin basic protein inhibits the calcium response to phytohaemagglutinin in human lymphocytes 148
Biochemical characterization of the natural Cys386-FX variant: a new tool to investigate coagulation factor X functions? 148
Purification of transglutaminase enzyme from L. infantum promastigotes 148
Allosteric inhibition of the water-soluble C-terminal fragment of Sendai virus neuraminidase 148
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 147
Totale 18.777
Salva come PNG Salva come JPEG
Categoria #
all - tutte 136.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 715
Totale 136.882
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.529 0 0 85 68 96 71 36 84 51 177 180 681
2022/20232.055 210 156 54 244 379 290 64 208 251 18 114 67
2023/2024843 93 123 48 30 81 120 16 60 15 15 21 221
2024/20253.743 101 80 335 147 496 266 146 202 542 471 531 426
2025/202610.695 1.047 513 1.005 1.401 1.538 679 1.154 525 1.093 1.133 420 187
2026/20271.451 278 625 548 0 0 0 0 0 0 0 0 0
Totale 30.201